MRE11A rs774277300: Understanding Genetic Cancer Predisposition

What each genotype means

What is rs774277300?

The variant rs774277300 is a specific single nucleotide polymorphism (SNP) located on chromosome 11 at position 94,447,276. In the context of human genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. This particular variant sits within the MRE11A gene, which provides instructions for making a protein essential for maintaining genomic stability. Because this variant is classified as rare, it is not found in the majority of the population. Researchers track such variants to understand how subtle changes in our genetic code might influence susceptibility to complex diseases, including various forms of cancer. While the presence of a variant can be identified through genetic testing, it is important to remember that the presence of a specific SNP does not automatically mean an individual will develop a disease, as many factors contribute to health outcomes.

The Role of the MRE11A Gene

The MRE11A gene, also known simply as MRE11, encodes a protein that acts as a nuclease, which is a type of enzyme capable of cleaving the phosphodiester bonds between nucleotide subunits of nucleic acids. This protein is a core component of the MRN complex, a critical molecular machine that detects and repairs double-strand breaks in DNA. By initiating homologous recombination, the MRN complex ensures that damaged DNA is repaired accurately, preventing the accumulation of mutations that could lead to cellular dysfunction or malignancy. Beyond its role in cancer susceptibility, mutations in the MRE11A gene have been linked to rare autosomal recessive conditions, such as ataxia-telangiectasia-like disorder (ATLD). Understanding the function of this gene is vital for researchers studying how DNA repair deficiencies can contribute to the development of hereditary cancer syndromes.

Research and Evidence Strength

Current research into rs774277300 suggests an association with hereditary cancer predisposition and an increased risk of colorectal cancer. However, the evidence supporting these links is considered moderate. Scientific literature often highlights that while rare variants can have significant impacts, their effects are frequently studied in specific cohorts, which may not represent the entire global population. It is common for initial findings regarding rare variants to require further validation through larger, multi-population studies to confirm the strength and consistency of the association. Because cancer is a multifactorial disease influenced by both genetics and environmental factors, the presence of this variant is just one piece of a much larger puzzle. Clinicians and researchers emphasize that genetic associations are statistical in nature and should not be interpreted as a definitive diagnosis or a guarantee of future health outcomes.

Population Frequency

The rs774277300 variant is documented as rare across human populations. Most individuals carry the common genotype, while the specific alleles associated with potential cancer risk are found at very low frequencies in the general population.

Navigating Genetic Information

If you have received information about your status for the rs774277300 variant, it is important to approach this data with perspective. Genetic testing results can be complex, and the clinical significance of rare variants is not always fully understood. You cannot use this information to self-diagnose or predict your health future with certainty. Instead, this information is best used as a tool for discussion with a qualified healthcare provider or a genetic counselor. They can help place your results in the context of your personal and family medical history. If you are concerned about your risk for colorectal cancer or other hereditary conditions, consult your physician to discuss appropriate screening protocols or clinical evaluations. Never make changes to your health management or medical care based solely on a genetic report without professional medical guidance.

Frequently asked questions

Sources & further reading